Literature DB >> 9751520

Growth hormone promotion of tubulin polymerization stabilizes the microtubule network and protects against colchicine-induced apoptosis.

E L Goh1, T J Pircher, P E Lobie.   

Abstract

We have investigated the effect of GH on microtubular physiology in Chinese hamster ovary (CHO) cells stably transfected with the complementary DNA for the rat GH receptor (CHO-GHR(1-638)). We show here that after 30 min of human GH (hGH) treatment of CHO-GHR(1-638) cells, there was a significant increase in the level of polymerization of all four tubulin isoforms (alpha-, beta-, gamma-, and tyrosinated alpha-tubulin) compared with the serum-deprived state. However, this transient increase in the levels of polymerized tubulin after hGH treatment was particularly pronounced for beta- and tyr alpha-tubulin. For alpha- and gamma-tubulin, the hGH-induced increase in polymerization state lasted to approximately 3 h and then declined by 7 h, whereas for beta- and tyr alpha-tubulin there was a decrease in the polymerization state at 1-2 h after hGH treatment compared with the level at 30 min (but still greater than the serum-deprived state) followed by a second but lesser wave of increased polymerization lasting to 7 h. The changes in the polymerization state of the tubulins were not accompanied by comparative changes in the level of total cellular tubulin. The proline rich box 1 region of the GH receptor was required for hGH to stimulate tubulin polymerization indicative that this event is JAK dependent. Increased tubulin polymerization still occurred in response to hGH in a receptor truncation lacking the carboxyl terminal half of the intracellular domain of the GH receptor indicative that hGH induced changes in intracellular calcium concentration is not required for tubulin polymerization. Prior treatment of CHO-GHR(1-638) cells with hGH retarded colchicine induced microtubule depolymerization and also prevented colchicine induced apoptotic cell death. The integrity of the microtubule network was not required for GH-induced STAT5 mediated transcription as treatment of cells with colchicine, vincristine, or vinblastine did not alter the fold stimulation of the STAT5 mediated transcriptional response to GH. Thus one consequence of cellular treatment with GH is alteration in microtubule physiology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751520     DOI: 10.1210/endo.139.10.6237

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo.

Authors:  Lei Gu; Paraskevi Vogiatzi; Martin Puhr; Ayush Dagvadorj; Jacqueline Lutz; Amy Ryder; Sankar Addya; Paolo Fortina; Carlton Cooper; Benjamin Leiby; Abhijit Dasgupta; Terry Hyslop; Lukas Bubendorf; Kalle Alanen; Tuomas Mirtti; Marja T Nevalainen
Journal:  Endocr Relat Cancer       Date:  2010-05-18       Impact factor: 5.678

2.  Activation of GH signaling and GH-independent stimulation of growth in zebrafish by introduction of a constitutively activated GHR construct.

Authors:  A S Ishtiaq Ahmed; Feng Xiong; Shao-Chen Pang; Mu-Dan He; Michael J Waters; Zuo-Yan Zhu; Yong-Hua Sun
Journal:  Transgenic Res       Date:  2010-08-29       Impact factor: 2.788

3.  Expression of a glycosylphosphatidylinositol-anchored ligand, growth hormone, blocks receptor signalling.

Authors:  François Guesdon; Yahia Kaabi; Aiden H Riley; Ian R Wilkinson; Colin Gray; David C James; Peter J Artymiuk; Jon R Sayers; Richard J Ross
Journal:  Biosci Rep       Date:  2012-12       Impact factor: 3.840

Review 4.  Recent advances in growth hormone signaling.

Authors:  Nathan J Lanning; Christin Carter-Su
Journal:  Rev Endocr Metab Disord       Date:  2006-12       Impact factor: 9.306

Review 5.  Growth Hormone Receptor Regulation in Cancer and Chronic Diseases.

Authors:  Ger J Strous; Ana Da Silva Almeida; Joyce Putters; Julia Schantl; Magdalena Sedek; Johan A Slotman; Tobias Nespital; Gerco C Hassink; Jan A Mol
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-18       Impact factor: 5.555

6.  TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype.

Authors:  Antonietta R Farina; Natalia Di Ianni; Lucia Cappabianca; Pierdomenico Ruggeri; Marzia Ragone; Giulia Ianni; Alberto Gulino; Andrew R Mackay
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.